Dongyuan Su

CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma

Yunfei Wang, Junhu Zhou, Jixing Zhao, 2024, Theranostics.

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.

Yunfei Wang, Jixing Zhao, Xiaoteng Cui, 2024, Cancer letters.

MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.

Qi-xue Wang, Jixing Zhao, Xiaoteng Cui, 2022, Pharmacological research.